Pulling SEC filings + quote and writing the call…
| Fiscal year | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|
| Operating income | — | — | -$12.0M | -$10.9M | -$8.66M | -$7.98M | -$9.07M |
| Net income | -$3.64K | -$1.63M | -$12.0M | -$10.8M | -$120K | -$15.0M | -$8.91M |
| EPS (diluted) | — | -$0.03 | -$42.50 | -$149.20 | -$8.44 | -$1,052.16 | -$23.95 |
| Fiscal year | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|
| Operating cash flow | — | -$217K | -$11.1M | -$11.2M | -$7.29M | -$18.3M | -$8.27M |
| Capital expenditures | — | — | $132K | — | — | $19.2K | — |
| Free cash flow | — | — | -$11.2M | — | — | -$18.3M | — |
| Share buybacks | — | — | $35.5M | $35.5M | — | — | — |
| Fiscal year | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|
| Cash & equivalents | — | $11.7K | $1.27M | $5.25M | $12.0M | $6.50M | $10.7M |
| Total assets | $22.7K | $74.2M | $2.04M | $5.50M | $12.2M | $6.62M | $11.6M |
| Total liabilities | $26.3K | $6.34M | $2.14M | $4.45M | $5.56M | $1.91M | $2.72M |
| Shareholders' equity | -$3.64K | $3.41M | -$99.5K | $1.05M | $6.65M | $4.71M | $8.86M |
| Retained earnings | -$3.64K | -$5.69M | -$14.5M | -$25.3M | -$25.5M | -$40.5M | -$49.4M |
| Shares (wtd avg diluted) | — | 2.41M | 282K | 72.6B | 14.2B | 14.3B | 621K |
Every figure is extracted from REVELATION BIOSCIENCES, INC.’s annual reports as filed with the SEC (XBRL company facts) — no third-party estimates. Fiscal years are labeled by period end; filers occasionally re-tag concepts, so a sparse cell means the company didn’t report that concept for that year. Free cash flow = operating cash flow − capital expenditures.
Research and education only — not financial advice. TENKis not a registered investment adviser or broker-dealer and gives no personalized advice. Every call is impersonal — identical for all users, generated on a schedule from SEC filings plus a delayed/third-party price feed — may be wrong or out of date, and is not a recommendation to buy or sell any security. The operator and an affiliated trading operation may hold or trade the securities TENK rates; see Disclosures. Past performance does not guarantee future results. Do your own research.